PMID- 25695811
OWN - NLM
STAT- MEDLINE
DCOM- 20160119
LR  - 20161125
IS  - 1660-8151 (Print)
IS  - 1660-8151 (Linking)
VI  - 129 Suppl 1
DP  - 2015
TI  - UK Renal Registry 17th Annual Report: Chapter 7 Haemoglobin, Ferritin and 
      Erythropoietin amongst UK Adult Dialysis Patients in 2013: National and 
      Centre-specific Analyses.
PG  - 143-67
LID - 10.1159/000370277 [doi]
AB  - BACKGROUND: The diagnosis and management of anaemia in chronic kidney disease and 
      the standards to be achieved have been detailed in the UK Renal Association 
      Anaemia of CKD guidelines. AIMS: To determine the attainment of standards for 
      anaemia management in the UK. METHODS: Quarterly data were obtained for 
      haemoglobin (Hb) and factors that influence Hb from renal centres in 
      England,Wales, Northern Ireland (EW&NI) and the Scottish Renal Registry for the 
      incident and prevalent renal replacement therapy (RRT) cohorts for 2013. RESULTS: 
      In the UK, in 2013,50% of patients commenced dialysis therapy with Hb 5100 g/L 
      (median Hb 100 g/L). Of patients presenting early, 53% started dialysis with Hb 
      5100 g/L compared to 36% of patients presenting late. The UK median Hb of 
      haemodialysis (HD) & peritoneal dialysis (PD) patients was 112 g/L 
      (inter-quartile range (IQR) 103-120 g/L) and 113 g/L(IQR 103-122 g/L) 
      respectively with 83% of patients having Hb .100 g/L for both treatment 
      modalities. The median ferritin in HD and PD patients was 424 mg/L (IQR 280-616 
      mg/L) and 285 mg/L (IQR 167-473 mg/L) respectively with the majority of patients 
      achieving ferritin 5100 mg/L.In EW&NI the median ESA dose was higher for HD than 
      PD patients (7,333 vs. 4,000 IU/week). The percentage of patients treated with an 
      ESA and having Hb .120 g/L ranged between centres from 3-29% for HD and from 
      0-26% for PD. CONCLUSIONS: There continues to be significant variation between 
      centres in the use of iron and ESAi n order to achieve the target Hb (100-120 
      g/L).
FAU - Gilg, Julie
AU  - Gilg J
AD  - UK Renal Registry, Bristol, UK.
FAU - Evans, Rebecca
AU  - Evans R
FAU - Rao, Anirudh
AU  - Rao A
FAU - Williams, Andrew J
AU  - Williams AJ
LA  - eng
PT  - Journal Article
DEP - 20150122
PL  - Switzerland
TA  - Nephron
JT  - Nephron
JID - 0331777
RN  - 0 (Hemoglobins)
RN  - 11096-26-7 (Erythropoietin)
RN  - 9007-73-2 (Ferritins)
SB  - IM
MH  - Adult
MH  - Erythropoietin/*metabolism
MH  - Ferritins/*metabolism
MH  - Hemoglobins/*metabolism
MH  - Humans
MH  - *Registries
MH  - *Renal Dialysis
MH  - United Kingdom
GN  - NLM: Original DateCompleted: 20150220
EDAT- 2015/02/20 06:00
MHDA- 2015/02/20 06:01
CRDT- 2015/02/20 06:00
PHST- 2015/02/20 06:00 [entrez]
PHST- 2015/02/20 06:00 [pubmed]
PHST- 2015/02/20 06:01 [medline]
AID - 000370277 [pii]
AID - 10.1159/000370277 [doi]
PST - ppublish
SO  - Nephron. 2015;129 Suppl 1:143-67. doi: 10.1159/000370277. Epub 2015 Jan 22.